Insulin, Asp(B28)-

DRUG5 trials

Sponsors

Legacy Health System, University of California, San Francisco, Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète, CeQur Corporation, Oxford University Hospitals NHS Trust

Conditions

DiabetesEnd Stage Renal DiseaseType 1 DiabetesType 2 Diabetes Mellitus

Phase 2

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

CompletedNCT00797823

Legacy Health SystemType 1 Diabetes

Start: 2008-11-30End: 2009-09-30Updated: 2011-10-07

Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital

CompletedNCT02101229

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du DiabèteType 1 Diabetes

Start: 2014-05-31End: 2015-02-28Updated: 2015-07-30

Phase 4

Additional Insulin for Fat and Protein in Children With Diabetes Study

TerminatedNCT02680054

Oxford University Hospitals NHS TrustType 1 Diabetes

Start: 2016-02-29End: 2018-08-31Updated: 2020-02-05

Unknown Phase

Hyperglycemia in Renal Transplantation

CompletedNCT01643382

University of California, San FranciscoDiabetes, End Stage Renal Disease

Start: 2012-08-31End: 2014-08-31Updated: 2020-11-05

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

CompletedNCT02419859

CeQur CorporationType 2 Diabetes Mellitus

Start: 2015-02-28End: 2015-11-30Updated: 2016-07-26

Related Papers

Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes

Diabetic Medicine2018-06-1117 citations